Latest Anthracyclines Stories
LOS ANGELES, May 1, 2015 /PRNewswire/ -- CytRx Corporation (CYTR), a biopharmaceutical research and development company specializing in oncology, today reported financial results for the three months
DSMB's recommendation follows 1(rst) interim analysis QUÉBEC CITY, April 27, 2015 /PRNewswire/ - Aeterna Zentaris Inc.
QUÉBEC CITY, April 16, 2015 /PRNewswire/ - Aeterna Zentaris Inc.
EWING, N.J., April 6, 2015 /PRNewswire/ -- Celator Pharmaceuticals, Inc.
LOS ANGELES, March 10, 2015 /PRNewswire/ -- CytRx Corporation (CYTR), a biopharmaceutical research and development company specializing in oncology, today reported financial results for the twelve
LAWRENCEVILLE, N.J., March 5, 2015 /PRNewswire/ -- Celsion Corporation (NASDAQ: CLSN) announced today that the Company will host a conference call to discuss year-end 2014 financial results
A Follow-On Combination Trial in First-Line Ovarian Cancer in the Neo-Adjuvant Setting Has Been Accepted by FDA LAWRENCEVILLE, N.J., Feb.
LAGUNA HILLS, Calif., Feb.
BIRMINGHAM, Ala., Jan.
Aldoxorubicin Demonstrates 2-Fold Increase in Likelihood of Surviving More than 2 Years versus Doxorubicin and 27% Reduction in the Risk of Death LOS ANGELES, Jan.
- a slit in a tire to drain away surface water and improve traction.